Legend Biotech

Legend Biotech is a clinical-stage biopharmaceutical company that discovers and develops novel cell therapies for oncology. The company develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Its initial product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma.

Domain

legendbiotech.com

Employees

1001-5000

Last Funding

$350.0M

Founded

2013

Frequently Asked Questions

What technologies does Legend Biotech use?+

Legend Biotech uses 17 technologies including Bootstrap, OWL Carousel, OneTrust.

What industry is Legend Biotech in?+

Legend Biotech operates in the Biotechnology industry.

Where is Legend Biotech based?+

Legend Biotech is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026